The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Antibody-Mediated Rejection Due to Preexisting versus De Novo Donor-Specific Antibodies in Kidney Allograft Recipients
Open accessAbstract
Antibody-mediated rejection (ABMR) can occur in patients with preexisting anti-HLA donor-specific antibodies (DSA) or in patients who develop de novo DSA. However, how these processes compare in terms of allograft injury and outcome has not been addressed. From a cohort of 771 kidney biopsy specimens from two North American and five European centers, we performed a systematic assessment of clinical and biologic parameters, histopathology, circulating DSA, and allograft gene expression for all patients with ABMR (n=205). Overall, 103 (50%) patients had preexisting DSA and 102 (50%) had de novo DSA. Compared with patients with preexisting DSA ABMR, patients with de novo DSA ABMR displayed increased proteinuria, more transplant glomerulopathy lesions, and lower glomerulitis, but similar levels of peritubular capillaritis and C4d deposition. De novo DSA ABMR was characterized by increased expression of IFN γ-inducible, natural killer cell, and T cell transcripts, but less expression of AKI transcripts compared with preexisting DSA ABMR. The preexisting DSA ABMR had superior graft survival compared with the de novo DSA ABMR (63% versus 34% at 8 years after rejection, respectively; P<0.001). After adjusting for clinical, histologic, and immunologic characteristics and treatment, we identified de novo DSA ABMR (hazard ratio [HR], 1.82 compared with preexisting DSA ABMR; 95% confidence interval [95% CI], 1.07 to 3.08; P=0.03); low eGFR (<30 ml/min per 1.73 m 2) at diagnosis (HR, 3.27; 95% CI, 1.48 to 7.23; P<0.001); ≥0.30 g/g urine protein-to-creatinine ratio (HR, 2.44; 95% CI, 1.47 to 4.09; P<0.001); and presence of cg lesions (HR, 2.25; 95% CI, 1.34 to 3.79; P=0.002) as the main independent determinants of allograft loss. Our findings support the transplant of kidneys into highly sensitized patients and should encourage efforts to monitor patients for de novo DSA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bootstrap methods: another look at the jackknife
Efron, B. (1979) · The Annals of Statistics · doi:10.1214/aos/1176344552 · Cited by 17,602
Sellarés, J., de Freitas, D. G., Mengel, M., Reeve, J., Einecke, G., Sis, B., Hidalgo, L. G., Famulski, K., Matas, A., & Halloran, P. F. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03840.x · Cited by 1,590
Self-citationHaas, M., Sis, B., Racusen, L. C., Solez, K., Glotz, D., Colvin, R. B., Castro, M. C. R., David, D. S. R., David-Neto, E., Bagnasco, S. M., et al. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12590 · Cited by 1,350
Self-citationThe Quality of Life of Patients with End-Stage Renal Disease
Evans, R. W., Manninen, D. L., Garrison, L. P., Hart, L. G., Blagg, C. R., Gutman, R. A., Hull, A. R., & Lowrie, E. G. (1985) · New England Journal of Medicine · doi:10.1056/nejm198502283120905 · Cited by 1,183
Wiebe, C., Gibson, I. W., Blydt-Hansen, T. D., Karpinski, M., Ho, J., Storsley, L. J., Goldberg, A., Birk, P. E., Rush, D. N., & Nickerson, P. W. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2012.04013.x · Cited by 950
Long-Term Renal Allograft Survival in the United States: A Critical Reappraisal
Lamb, K. E., Lodhi, S., & Meier-Kriesche, H.-U. (2011) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2010.03283.x · Cited by 916
Comparison of Survival Probabilities for Dialysis Patients vs Cadaveric Renal Transplant Recipients
Port, F. K. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510110079036 · Cited by 825
Preexisting Donor-Specific HLA Antibodies Predict Outcome in Kidney Transplantation
Lefaucheur, C., Loupy, A., Hill, G. S., Andrade, J., Nochy, D., Antoine, C., Gautreau, C., Charron, D., Glotz, D., & Suberbielle-Boissel, C. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009101065 · Cited by 789
Self-citationSis, B., Mengel, M., Haas, M., Colvin, R. B., Halloran, P. F., Racusen, L. C., Solez, K., Baldwin, W. M., Bracamonte, E. R., Broecker, V., et al. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02987.x · Cited by 762
Self-citationRituximab and Intravenous Immune Globulin for Desensitization during Renal Transplantation
Vo, A. A., Lukovsky, M., Toyoda, M., Wang, J., Reinsmoen, N. L., Lai, C.-H., Peng, A., Villicana, R., & Jordan, S. C. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707894 · Cited by 692
Desensitization in HLA-Incompatible Kidney Recipients and Survival
Montgomery, R. A., Lonze, B. E., King, K. E., Kraus, E. S., Kucirka, L. M., Locke, J. E., Warren, D. S., Simpkins, C. E., Dagher, N. N., Singer, A. L., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1012376 · Cited by 687
Antibody-Mediated Microcirculation Injury Is the Major Cause of Late Kidney Transplant Failure
Einecke, G., Sis, B., Reeve, J., Mengel, M., Campbell, P. M., Hidalgo, L. G., Kaplan, B., & Halloran, P. F. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02799.x · Cited by 687
Self-citationRejection of the Kidney Allograft
Nankivell, B. J., & Alexander, S. I. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0902927 · Cited by 605 · cited 3×
“The transcripts mostly associated with preexisting anti-HLA ABMR were: (1) natural killer cell–selective transcripts CCL4, KLRD1, SH2D1B, CD160, and NCR1; (2) endothelial and IFNginducible genes including chemokines Table 2.”
BackgroundMethodSis, B., Jhangri, G. S., Bunnag, S., Allanach, K., Kaplan, B., & Halloran, P. F. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02761.x · Cited by 478
Self-citationHidalgo, L. G., Sis, B., Sellares, J., Campbell, P. M., Mengel, M., Einecke, G., Chang, J., & Halloran, P. F. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2010.03201.x · Cited by 428
Self-citationStegall, M. D., Gloor, J., Winters, J. L., Moore, S. B., & DeGoey, S. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.01178.x · Cited by 428
Banff 2011 Meeting Report: New Concepts in Antibody-Mediated Rejection
Mengel, M., Sis, B., Haas, M., Colvin, R. B., Halloran, P. F., Racusen, L. C., Solez, K., Cendales, L., Demetris, A. J., Drachenberg, C. B., et al. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03926.x · Cited by 399
Self-citationSurvival Benefit with Kidney Transplants from HLA-Incompatible Live Donors
Orandi, B. J., Luo, X., Massie, A. B., Garonzik-Wang, J. M., Lonze, B. E., Ahmed, R., Van Arendonk, K. J., Stegall, M. D., Jordan, S. C., Oberholzer, J., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1508380 · Cited by 364
Hidalgo, L. G., Campbell, P. M., Sis, B., Einecke, G., Mengel, M., Chang, J., Sellares, J., Reeve, J., & Halloran, P. F. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02800.x · Cited by 308
Self-citationLefaucheur, C., Nochy, D., Andrade, J., Verine, J., Gautreau, C., Charron, D., Hill, G. S., Glotz, D., & Suberbielle-Boissel, C. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02591.x · Cited by 291
Self-citationMolecular Diagnosis of T Cell-Mediated Rejection in Human Kidney Transplant Biopsies
Reeve, J., Sellarés, J., Mengel, M., Sis, B., Skene, A., Hidalgo, L., de Freitas, D. G., Famulski, K. S., & Halloran, P. F. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12079 · Cited by 228
Self-citationAubert, O., Kamar, N., Vernerey, D., Viglietti, D., Martinez, F., Duong-Van-Huyen, J.-P., Eladari, D., Empana, J.-P., Rabant, M., Verine, J., et al. (2015) · BMJ · doi:10.1136/bmj.h3557 · Cited by 190
Self-citationHalloran, P. F., Pereira, A. B., Chang, J., Matas, A., Picton, M., De Freitas, D., Bromberg, J., Serón, D., Sellarés, J., Einecke, G., et al. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12465 · Cited by 186
Self-citationMolecular Phenotypes of Acute Kidney Injury in Kidney Transplants
Famulski, K. S., de Freitas, D. G., Kreepala, C., Chang, J., Sellares, J., Sis, B., Einecke, G., Mengel, M., Reeve, J., & Halloran, P. F. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011090887 · Cited by 169
Self-citationVenner, J. M., Hidalgo, L. G., Famulski, K. S., Chang, J., & Halloran, P. F. (2015) · American Journal of Transplantation · doi:10.1111/ajt.13115 · Cited by 166
Self-citationWalsh, R. C., Brailey, P., Girnita, A., Alloway, R. R., Shields, A. R., Wall, G. E., Sadaka, B. H., Cardi, M., Tevar, A., Govil, A., et al. (2011) · Transplantation · doi:10.1097/tp.0b013e318218e901 · Cited by 162
Quantifying Renal Allograft Loss Following Early Antibody-Mediated Rejection
Orandi, B. J., Chow, E. K. H., Hsu, A., Gupta, N., Arendonk, K. J. V., Garonzik‐Wang, J., Montgomery, J. R., Wickliffe, C. E., Lonze, B. E., Bagnasco, S. M., et al. (2015) · American Journal of Transplantation · doi:10.1111/ajt.12982 · Cited by 113
(2011) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03886.x · Cited by 100
Bagnasco, S. M., Zachary, A. A., Racusen, L. C., Arend, L. J., Carter‐Monroe, N., Alachkar, N., Nazarian, S. M., Lonze, B. E., Montgomery, R. A., & Kraus, E. S. (2013) · Transplantation · doi:10.1097/01.tp.0000437177.40551.f4 · Cited by 60
HLA-Incompatible Kidney Transplantation — Worth the Risk?
Rostaing, L. P. E., & Malvezzi, P. (2016) · New England Journal of Medicine · doi:10.1056/nejme1601379 · Cited by 22
Cited by
Haas, M., Loupy, A., Lefaucheur, C., Roufosse, C., Glotz, D., Seron, D., Nankivell, B. J., Halloran, P. F., Colvin, R. B., Akalin, E., et al. (2018) · American Journal of Transplantation · doi:10.1111/ajt.14625 · Cited by 1,041
Self-citationSchinstock, C. A., Mannon, R. B., Budde, K., Chong, A. S., Haas, M., Knechtle, S., Lefaucheur, C., Montgomery, R. A., Nickerson, P., Tullius, S. G., et al. (2020) · Transplantation · doi:10.1097/tp.0000000000003095 · Cited by 345
Self-citationSensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group Meeting Report
Tambur, A. R., Campbell, P., Claas, F. H., Feng, S., Gebel, H. M., Jackson, A. M., Mannon, R. B., Reed, E. F., Tinckam, K., Askar, M., et al. (2018) · American Journal of Transplantation · doi:10.1111/ajt.14752 · Cited by 297
Self-citation
Metadata
- Authors
- Aubert, O., Loupy, A., Hidalgo, L., Duong van Huyen, J.-P., Higgins, S., Viglietti, D., Jouven, X., Glotz, D., Legendre, C., Lefaucheur, C., & Halloran, P. F.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2017-03-02
- Volume
- 28
- Issue
- 6
- Pages
- 1912-1923
- ISSN
- 1046-6673 (ISSN-L)
- 1533-3450
- OpenAlex
- W2592185057
- Cited by
- 259
- References
- 30
- FWCI
- 25.24
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.